Comparison of intracoronary vs. intravenous administration of abciximab in coronary stenting
β Scribed by Aman K. Kakkar; Ali Moustapha; Henry G. Hanley; Mitchell Weiss; Gloria Caldito; Praphul Misra; Pratap C. Reddy; Neeraj Tandon
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 54 KB
- Volume
- 61
- Category
- Article
- ISSN
- 1522-1946
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Growth factor-induced angiogenesis is being investigated in ischemic heart disease. Intracoronary and intravenous delivery are the most practical, but are limited by low myocardial uptake and significant systemic recirculation. The pericardial space may act as a drug delivery reservoir with increase
We report the use of coronary stenting to treat disease in an anomalous coronary artery. The patient had a single coronary artery with anomalous left anterior descending artery arising from the right sinus of Valsalva and coursing between the aorta and pulmonary artery. Although balloon angioplasty
Danielle Hupkens van der Elst, and Harry van der Lubbe Coronary Palmaz Schatz stent implantation is usually performed by using the sheath protected stent delivery system (SDS) via the percutaneous transfemoral route. However, downsizing of PTCA equipment made transradial coronary stenting feasible.